Correlation Between Oncopeptides and Lime Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Lime Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Lime Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Lime Technologies AB, you can compare the effects of market volatilities on Oncopeptides and Lime Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Lime Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Lime Technologies.

Diversification Opportunities for Oncopeptides and Lime Technologies

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Oncopeptides and Lime is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Lime Technologies AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lime Technologies and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Lime Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lime Technologies has no effect on the direction of Oncopeptides i.e., Oncopeptides and Lime Technologies go up and down completely randomly.

Pair Corralation between Oncopeptides and Lime Technologies

Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Lime Technologies. In addition to that, Oncopeptides is 1.84 times more volatile than Lime Technologies AB. It trades about -0.16 of its total potential returns per unit of risk. Lime Technologies AB is currently generating about 0.21 per unit of volatility. If you would invest  32,800  in Lime Technologies AB on September 1, 2024 and sell it today you would earn a total of  4,550  from holding Lime Technologies AB or generate 13.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oncopeptides AB  vs.  Lime Technologies AB

 Performance 
       Timeline  
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Lime Technologies 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lime Technologies AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Lime Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Oncopeptides and Lime Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncopeptides and Lime Technologies

The main advantage of trading using opposite Oncopeptides and Lime Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Lime Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lime Technologies will offset losses from the drop in Lime Technologies' long position.
The idea behind Oncopeptides AB and Lime Technologies AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon